Analyst Ratings for Vir Biotechnology (VIR)
VIR Rating Summary
VIR Price Target Summary
- Highest: $30.00 (Barclays)
- Lowest: $13.00 (BofA Securities)
- Average: $20.25
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$20.25 (+112%)
* Over Last 12-Mos
Rating Score: 9.1 / 10
Percentile Rank: 90%
Avg. $ Target:
$20.25 (+112%)
* Over Last 12-Mos
Rating Score: 9.1 / 10
Percentile Rank: 90%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/24/2026 | Raymond James | Sean McCutcheon | Upgrade | Strong Buy (Outperform) |
19.00 (12.00) |
7.43 (9.55) |
28.53% | Details |
| 9/3/2025 | Evercore ISI » Updated 2/24/2026 |
Cory Kasimov | New Coverage | Outperform (N/A) |
18.00 (12.00) |
5.00 (9.55) |
91% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
